⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6125672 | 1.00 | — | — | |
| SCHEMBL21798657 | 1.00 | — | — | |
| SCHEMBL12465810 | 0.82 | — | — | |
| SCHEMBL28954718 | 0.78 | — | — | |
| SCHEMBL960450 | 0.72 | OPRL1 (0.32) | — | |
| SCHEMBL27877545 | 0.69 | SMYD3 (0.40) | — | |
| SCHEMBL8763503 | 0.69 | OPRL1 (0.31) | — | |
| SCHEMBL5197844 | 0.68 | — | — | |
| SCHEMBL18988280 | 0.65 | — | — | |
| SCHEMBL27775704 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128616-A1 | COMPOUNDS FOR TREATING CANCER | GENESIS THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| CN-108727363-B | Novel cyclin dependent kinase CDK9 inhibitor | 劲方医药科技(上海)有限公司 | 2020-06-19 | — | — | CN | disclosed |
| US-20200078343-A1 | NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9 | Shanghai Jiongshuo Pharmaceutical Technology Co., Ltd. (CN) | 2020-03-12 | — | — | US | disclosed |
| WO-2012066065-A1 | PHENYL-HETEROARYL AMINE COMPOUNDS AND THEIR USES | NOVARTIS AG (CH) | 2012-05-24 | — | — | WO | disclosed |